OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
16
Results
Show all
Save search
Copy query
Show results for
Unknown
(16)
Publication Date
Release Date
2022
(4)
2019
(4)
2023
(3)
2021
(2)
2025
(1)
2024
(1)
2020
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Patient treatment and outcome after breast cancer orbital and periorbital metastases: a comprehensive case series including analysis of lobular versus ductal tumor histology.
Not available
S-EPMC7318761
|
biostudies-literature
Cite
Targeted mutation detection in breast cancer using MammaSeq™.
Not available
S-EPMC6368740
|
biostudies-literature
Cite
Frequent amplifications of ESR1, ERBB2 and MDM4 in primary invasive lobular breast carcinoma.
Not available
S-EPMC6682463
|
biostudies-literature
Cite
Hotspot ESR1 Mutations Are Multimodal and Contextual Modulators of Breast Cancer Metastasis.
Not available
S-EPMC8983597
|
biostudies-literature
Cite
Disparities in seizure outcomes revealed by large language models.
Not available
S-EPMC11105138
|
biostudies-literature
Cite
Metastatic breast cancers have reduced immune cell recruitment but harbor increased macrophages relative to their matched primary tumors.
Not available
S-EPMC6798422
|
biostudies-literature
Cite
Gut microbiota density influences host physiology and is shaped by host and microbial factors.
Not available
S-EPMC6342524
|
biostudies-literature
Cite
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer.
Not available
S-EPMC10518255
|
biostudies-literature
Cite
Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8830904
|
biostudies-literature
Cite
Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial.
Not available
S-EPMC8598213
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets